International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study

Chaudhuri, Kallol Ray, Martinez‐Martin, Pablo, Schapira, Anthony H.V., Stocchi, Fabrizio, Sethi, Kapil, Odin, Per, Brown, Richard G., Koller, William +14 more·2006·Movement Disorders
DOI 10.1002/mds.20844

Cited by (1,001)

Items 601–700 of 1,001

  1. Trastornos no motores en la enfermedad de Parkinson
    Marcelo Merello · 2008 · Revista de Neurología
  2. The nutritional status of Dutch elderly patients with Parkinson's disease
    J. van Steijn, Barbera van Harten, E. Flapper, Erika Droogsma, P. Van Walderveen, M. Blaauw, Dieneke van Asselt · 2014 · The journal of nutrition health & aging
  3. Features associated with the development of non-motor manifestations in Parkinson's disease
    Carlos Juri C, Paola Viviani G, Pedro Chaná · 2008 · Arquivos de Neuro-Psiquiatria
  4. Calidad de vida en pacientes con enfermedad de Parkinson
    Elizabeth Martínez-Jurado, Amin Cervantes‐Arriaga, Mayela Rodríguez‐Violante · 2010
  5. Prevalence of Convergence Insufficiency-Type Symptomatology in Parkinson’s Disease
    Caroline Law, Estefania Chriqui, Marie‐Jeanne Kergoat, Bernard‐Simon Leclerc, Michel Panisset, Elizabeth L. Irving, Ronald B. Postuma, Sylvain Chouinard, Hélène Kergoat · 2017 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  6. Non-Motor Symptoms Burden in Early Stages of Parkinson's Disease
    Zomer Sardar, Sumayyah Liaquat, Qudsum Yousaf, Safia Bano, Ahsan Numan · 2022 · Annals of Indian Academy of Neurology
  7. Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells
    Ana Florencia Vega-Benedetti, Clara Porcedda, Tommaso Ercoli, Giuliana Fusco, Chiara Burgaletto, Rita Pillai, Francesca Palmas, Anna Flavia Cantone, Fabrizio Angius, Paolo Solla et al. · 2024 · Journal of Neurology
  8. Elevation of Plasma Homocysteine and Minor Hallucinations in Parkinson’s Disease: A Cross-Sectional Study
    Min Zhong, Sha Zhu, Ruxin Gu, Yaxi Wang, Yinyin Jiang, Yu Bai, Xu Jiang, Bo Shen, Jun Yan, Yang Pan et al. · 2022 · Behavioural Neurology
  9. Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S Variant
    Rachel J. Saunders-Pullman, Roberto Angel Ortega, Cuiling Wang, Deborah Raymond, Sonya Elango, Katherine R. Leaver, Nikita Urval, Viktoriya Katsnelson, Rachel Gerber, Matthew Carrington Swan et al. · 2022 · Neurology
  10. Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel
    Rajesh Pahwa, Stuart Isaacson, Gary W. Small, Yasar A. Torres-Yaghi, Fernando Pagán, Marwan Noel Sabbagh · 2022 · Neurology and Therapy
  11. Assessment of the neuroprotective effect of green synthesized iron oxide nanoparticles capped with curcumin against a rat model of Parkinson's disease.
    Yasser A. Khadrawy, Eman Nasr Hosny, Haitham S Mohamed · 2024 · PubMed Central
  12. Non-motor symptoms in Indian patients with Parkinson’s disease
    Aaron de Souza, Varun R. Pai Kakode, Zico D’Costa, Siddesh K. Bhonsle · 2015 · Basal Ganglia
  13. Instruments for holistic assessment of Parkinson’s disease
    Pablo Martínez‐Martín · 2013 · Journal of Neural Transmission
  14. Nonmotor Symptoms Groups in Parkinson's Disease Patients: Results of a Pilot, Exploratory Study
    Santiago Perez‐Lloret, Malco Rossi, Marcelo Merello, Olivier Rascol, Daniel Pedro Cardinali · 2011 · Parkinson s Disease
  15. Non-Motor Correlates of Smoking Habits in de Novo Parkinson’s Disease
    Marcello Moccia, Brit Mollenhauer, Roberto Erro, Marina Picillo, Raffaele Palladino, Paolo Barone · 2015 · Journal of Parkinson s Disease
  16. Evaluation of an Arabic version of the non-motor symptoms scale in Parkinson’s disease
    Leila Sellami, Imen Kacem, Amina Nasri, Mouna Ben Djebara, Youssef Sidhom, Amina Gargouri, Riadh Gouider · 2016 · Neurological Sciences
  17. CSF Aβ1–42 level is associated with cognitive decline in early Parkinson’s disease with rapid eye movement sleep behavior disorder
    Maowen Ba, Guoping Yu, Min Kong, Hui Wen Liang, Ling Yu · 2018 · Translational Neurodegeneration
  18. Effects of Qigong Exercise on Non-Motor Symptoms and Inflammatory Status in Parkinson’s Disease: A Protocol for a Randomized Controlled Trial
    Sanghee Moon, Caio V. M. Sarmento, I. Smirnova, Yvonne Colgrove, K. Lyons, S. Lai, Wen Liu · 2019 · Medicines
  19. Putaminal Dopamine Turnover in de novo Parkinson’s Disease Predicts Later Neuropsychiatric Fluctuations but Not Other Major Health Outcomes
    Matthias Löhle, Wiebke Hermann, Denise Hausbrand, Martin Wolz, Julia Mende, Bettina Beuthien‐Baumann, Liane Oehme, Jörg van den Hoff, Jörg Kotzerke, Heinz Reichmann et al. · 2019 · Journal of Parkinson s Disease
  20. Restless legs syndrome - the under-recognised non-motor burden: a questionnaire-based cohort study
    Anna Sauerbier, Chaamanti Sivakumar, Lisa Klingelhoefer, Pablo Martínez‐Martín, Lauren Perkins, Rona Inniss, Alexandra Rizos, Dhaval Trivedi, Valentina Leta, Yi-Min Wan et al. · 2019 · Postgraduate Medicine
  21. Predictive Factors of Concerns about Falling in People with Parkinson’s Disease: A 3-Year Longitudinal Study
    Magnus Lindh-Rengifo, Stina B. Jonasson, Niklas Mattsson, Susann Ullén, Maria H Nilsson · 2019 · Parkinson s Disease
  22. The effects of chronic subthalamic stimulation on nonmotor symptoms in advanced Parkinson’s disease, revealed by an online questionnaire program
    Minako Kawaguchi, Kazuhiro Samura, Yasushi Miyagi, Tsuyoshi Okamoto, Ryo Yamasaki, Nobutaka Sakae, Fumiaki Yoshida, Koji Iihara · 2020 · Acta Neurochirurgica
  23. Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey
    EUROPAR and the IPMDS Non-Motor PD Study Group, Alexandra Rizos, Anna Sauerbier, Cristian Falup‐Pecurariu, Per Odin, Angelo Antonini, Pablo Martínez‐Martín, B. Kessel, Tove Henriksen, Monty Silverdale et al. · 2020 · Journal of Neural Transmission
  24. Nonmotor symptoms and quality of life in Parkinson’s disease with different motor subtypes
    Dongdong Wu, Wen Su, Jing He, Shu-Hua Li, Kai Li, Haibo Chen · 2021 · Zeitschrift für Gerontologie und Geriatrie
  25. Gut microbiota in Parkinson’s disease patients: hospital-based study
    Eman Mohamed Khedr, Anwar Mohamed Ali, Enas Daef, Hebatallah M. Hassan, Ahmed Alaa, Ayman Gamea · 2021 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
  26. Lifelong constipation in Parkinson's disease and other clinically defined alpha-synucleinopathies: A population-based study in Southeast Minnesota
    Emanuele Camerucci, Aidan F. Mullan, James H. Bower, Adil E. Bharucha, Pierpaolo Turcano, Cole D. Stang, Eduardo Elias Benarroch, Bradley F. Boeve, J. Eric Ahlskog, Rodolfo Savica · 2022 · Parkinsonism & Related Disorders
  27. Trastornos digestivos en la enfermedad de Parkinson: disfagia y sialorrea
    Jimena González Fernández, Rosa Prieto Tedejo, Leticia Velasco Palacios, Sandra Jorge Roldán, Esther Cubo Delgado · 2010 · Revista de Neurología
  28. Data-driven subtyping of Parkinson’s disease: comparison of current methodologies and application to the Bochum PNS cohort
    Qiang Chen, Raphael Scherbaum, Ralf Gold, Kalliopi Pitarokoili, Axel Mosig A, Samis M. A. Zella, Lars Tönges · 2023 · Journal of Neural Transmission
  29. Repetitive transcranial magnetic stimulation for apathy in patients with neurodegenerative conditions, cognitive impairment, stroke, and traumatic brain injury: a systematic review
    Adrian Isidoro Espiritu, Takatoshi Hara, Joy Kirsten Tolledo, Mervin Blair, Amer M. Burhan · 2023 · Frontiers in Psychiatry
  30. Non-Motor Symptom Management: Insights into Adherence to Treatment Guidelines in Parkinson’s Disease Patients
    Carin Janz, Jonathan Timpka, Kristina Rosqvist, Gesine Paul, Alexander Storch, Per Odin · 2024 · Journal of Parkinson s Disease
  31. Influence of cognitive reserve on cognitive and motor function in α-synucleinopathies: A systematic review and multilevel meta-analysis
    Isaac Saywell, Lauren M. Foreman, Brittany Child, Alexander L. Phillips‐Hughes, Lyndsey E. Collins‐Praino, Irina Baetu · 2024 · Neuroscience & Biobehavioral Reviews
  32. Cognitive training and promoting a healthy lifestyle for individuals with isolated REM sleep behavior disorder: study protocol of the delayed-start randomized controlled trial CogTrAiL-RBD
    Anja Ophey, Sinah Röttgen, Julia Pauquet, Kim-Lara Weiß, Daniel Scharfenberg, Christopher E. J. Doppler, Aline Seger, Clint Hansen, Gereon R. Fink, Michael Sommerauer et al. · 2024 · Trials
  33. Longitudinal evaluation of polyneuropathy in Parkinson’s disease
    Eun Hae Kwon, Antonia Bieber, Paula Schülken, Katharina Müller, Eva M. Kuhn, Paulina Averdunk, Saskia Kools, Lovis Hilker, A. Kirchgässler, Lea Ebner et al. · 2024 · Journal of Neurology
  34. Pharmacological and non-pharmacological management of sleep disturbances in Parkinson’s disease: if when and how
    Cristian Falup‐Pecurariu, Maria‐Lucia Muntean, Larisa Ungureanu, Iulia Murășan, Karolina Popławska-Domaszewicz, К. Ray Chaudhuri, Ștefania Diaconu · 2024 · Expert Opinion on Pharmacotherapy
  35. Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease
    Mezin Öthman, Filip Bergquist, Per Odin, Monica Scharfenort, Anders Johansson, Ioanna Markaki, Per Svenningsson, Nil Dizdar, Dag Nyholm · 2024 · European Journal of Neurology
  36. Validation of the International Parkinson and Movement Disorder Society Non‐Motor Symptoms Questionnaire (MDS‐NMS‐Q)
    Daniel Weintraub, K. R. Chaudhuri, A. Schrag, P. Martinez-Martin, A. Rizos, E. Mamikonyan, Julia Gallagher, Izabelle Schoen, J. Staunton, Marta Fernandes et al. · 2025 · Movement Disorders
  37. Dysphagia in Parkinson’s Disease
    Emilia Michou, Christopher Kobylecki, Shaheen Hamdy · 2017 · Medical radiology
  38. Coping Styles among People with Parkinson’s Disease: A Three-Year Follow-Up Study
    Maria H Nilsson, Frank Oswald, Sebastian Palmqvist, Björn Slaug · 2020 · Behavioral Sciences
  39. Needs of patients with parkinsonism and their caregivers: a protocol for the PRIME-UK cross-sectional study
    Emma Tenison, Fiona E. Lithander, Matthew D. Smith, Danielle Pendry-Brazier, Yoav Ben‐Shlomo, Emily J. Henderson · 2022 · BMJ Open
  40. Health care experiences of people with Parkinson’s disease in Australia
    Mary E. Danoudis, Sze‐Ee Soh, Robert Iansek · 2023 · BMC Geriatrics
  41. Protocol for a multicentre cross-sectional, longitudinal ambulatory clinical trial in rheumatoid arthritis and Parkinson’s disease patients analysing the relation between the gut microbiome, fasting and immune status in Germany (ExpoBiome)
    Bérénice Hansen, Cedric Christian Laczny, Velma T. E. Aho, Audrey Frachet-Bour, Janine Habier, Marek Ostaszewski, Andreas Michalsen, Etienne Hanslian, Daniela A. Koppold, Anika M. Hartmann et al. · 2023 · BMJ Open
  42. The association between clinically relevant anxiety and other non-motor symptoms in Parkinson’s disease
    Siming Jiang, Yongsheng Yuan, Qing Tong, Li Zhang, Qinrong Xu, Jian Ding, Kezhong Zhang · 2015 · Neurological Sciences
  43. Botulinum toxin for drooling in Parkinson’s disease
    Fiona Hill, Nick Miller, Richard A. Walsh, David Mockler, Ronald D. McDowell, Margaret Walshe · 2016 · Cochrane Database of Systematic Reviews
  44. Pancreatic Polypeptide in Parkinson’s Disease: A Potential Marker of Parasympathetic Denervation
    Karoline Knudsen, Bolette Hartmann, Tatyana Dmitrievna Fedorova, Karen Østergaard, Klaus Krogh, Niels Møller, Jens Juul Holst, Per Borghammer · 2017 · Journal of Parkinson s Disease
  45. Double vision in Parkinson’s Disease: a systematic review
    Katarzyna Śmiłowska, Bogumił Wowra, Jarosław W. Sławek · 2020 · Neurologia i Neurochirurgia Polska
  46. Self-Reported Visual Complaints in People with Parkinson’s Disease: A Systematic Review
    Iris van der Lijn, Gera A. de Haan, Famke Huizinga, Fleur E. van der Feen, A. Wijnand F. Rutgers, Catherina Stellingwerf, Teus van Laar, Joost Heutink · 2022 · Journal of Parkinson s Disease
  47. Rivastigmine for the treatment of dementia associated with Parkinson’s disease
    John C. Morgan · 2008 · Neuropsychiatric Disease and Treatment
  48. Subthalamic stimulation improves the cerebral hemodynamic response to the cold pressure test in patients with Parkinson's disease
    Tõnu Rätsep, Toomas Asser · 2012 · Journal of Clinical Ultrasound
  49. Non-motor symptoms of Parkinson’s disease: the submerged part of the iceberg
    Natalia V. Titova, К. Ray Chaudhuri · 2017 · Annals of Clinical and Experimental Neurology
  50. Identifying prodromal symptoms at high specificity for Parkinson’s disease
    Holly Jackson, Judith Anzures‐Cabrera, Tanya Simuni, Ronald B. Postuma, KENNETH L. MAREK, Gennaro Pagano · 2023 · Frontiers in Aging Neuroscience
  51. Cholinergic dysfunction in isolated rapid eye movement sleep behaviour disorder links to impending phenoconversion
    Miriam Højholt Terkelsen, Álex Iranzo, Mónica Serradell, Andreas Myhre Baun, Morten Gersel Stokholm, Erik Hvid Danielsen, Karen Østergaard, Marit Otto, Kristina Bacher Svendsen, Mette Møller et al. · 2024 · European Journal of Neurology
  52. Efficacy, safety and patient’s quality of life of long-term treatment with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease in Romania: Results from GLORIA observational study
    József Attila Szász, Mihaela Adriana Simu, Lăcrămioara Perju‐Dumbravă, Angelo Antonini, Lars Bergmann, Diana Popescu, AbbVie SLR, Bucharest, Romania, Ovidiu Alexandru Bajenaru · 2020 · Romanian Journal of Neurology
  53. A novel neuroprotective cholinesterase-monoamine oxidase inhibitor for treatment of dementia and depression in Parkinson’s disease
    Wei Liu, Yuqiang Wang, Moussa B. H. Youdim · 2022 · Ageing and Neurodegenerative Diseases
  54. Divergence Between Informant and Self-Ratings of Activities of Daily Living Impairments in Parkinson’s Disease
    Sara Becker, Susanne Solbrig, Katja Michaelis, Bettina Faust, Kathrin Brockmann, Inga Liepelt‐Scarfone · 2022 · Frontiers in Aging Neuroscience
  55. Non-motor manifestation of Parkinson's disease: a cross-sectional study in a teaching hospital in Jordan
    Said Salah Dahbour, Mohammad J. Al Murr, Liyana Oweis, Nada Al‐Antary, Maram Mohsen, Safa Al Fegi · 2022 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
  56. Development of a machine learning-based Parkinson's disease prediction system through Ayurvedic dosha analysis
    Vinayak Majhi, Bishnu Choudhury, Goutam Kumar Saha, Sudip Paul · 2023 · International Journal of Ayurvedic Medicine
  57. Parkinsonism in a pair of monozygotic CADASIL twins sharing the R1006C mutation: a transcranial sonography study
    Michele Ragno, Sandro Sanguigni, Antonio Manca, Luigi Pianese, Cristina Paci, Alfonso Berbellini, Valeria Cozzolino, Roberto Gobbato, Silvio Peluso, Giuseppe De Michele · 2016 · Neurological Sciences
  58. Early Onset Parkinson’s Disease in a family of Moroccan origin caused by a p.A217D mutation in PINK1: a case report
    Brendan P. Norman, Steven J Lubbe, Manuela M. X. Tan, Naomi Warren, Huw R. Morris · 2017 · BMC Neurology
  59. Analysis of the clinical features of early Parkinson’s disease with comparatively integrated intestinal function
    Xiaoxue Guan, Yuchan Wang, Qun Li, Ming Wei, Lili Chen, Oumei Cheng · 2018 · Neurological Sciences
  60. Mediating Effect of Mutuality on Health-Related Quality of Life in Patients with Parkinson’s Disease
    Michaela Karlstedt, Seyed‐Mohammad Fereshtehnejad, Dag Aarsland, Johan Lökk · 2018 · Parkinson s Disease
  61. Detecting Apathy in Individuals with Parkinson’s Disease: A Systematic Review
    B. Mele, Daria Merrikh, Z. Ismail, Zahra Goodarzi · 2019 · Journal of Parkinson's Disease
  62. A randomized controlled efficacy study of the Medido medication dispenser in Parkinson’s disease
    K. Hannink, L. ter Brake, Nicol G. M. Oonk, A.A. Wertenbroek, M. Piek, L. Vree-Egberts, Marjan J. Faber, Job A.M. van der Palen, Lucille D.A. Dorresteijn · 2019 · BMC Geriatrics
  63. Analysis of the effects of subthalamic nucleus deep brain stimulation on somatosensation in Parkinson’s disease patients
    Esra Doğru Hüzmeli, Atilla Yılmaz, Esra Emine Okuyucu · 2019 · Neurological Sciences
  64. Parkinsonism
    Stanley Fahn, Joseph J. Jankovic, Mark Hallett · 2011 · Elsevier eBooks
  65. Clinical and Genetic Analysis of Psychosis in Parkinson’s Disease
    Branislava Radojević, Nataša Mišković, Ana Marjanović, Marija Branković, Valerija Dobričić, Andona Milovanović, Aleksandra Tomić, Marina V. Svetel, Igor N. Petrović, Ivan Jančić et al. · 2021 · Journal of Parkinson s Disease
  66. Elevated serum anti‐ Saccharomyces cerevisiae antibody accompanied by gut mycobiota dysbiosis as a biomarker of diagnosis in patients with de novo Parkinson disease
    Ying Chen, Liying Zhang, Yi Fang, Chuan Li, Dan‐Dan Xia, Gong Zhang, Yi Wen, Song-zhao Zhang, Liu Hu, Luyan Gu et al. · 2023 · European Journal of Neurology
  67. Burden of nonmotor symptoms in Parkinson’s disease patients from eastern India
    Sulagna Sahu, Adreesh Mukherjee, Samar Biswas, Valentina Leta, Katarina Rukavina, Shyamal Kumar Das, Atanu Biswas · 2021 · Annals of Movement Disorders
  68. Treatment Challenges in Parkinson's Disease
    Mickie D. Welsh · 2008 · The Nurse Practitioner
  69. Monitoring Parkinson's Disease Progression Using Behavioural Inferences, Mobile Devices and Web Technologies
    Julio Vega · 2016 · International World Wide Web Conference (WWW)
  70. Housing accessibility problems for people with Parkinson's disease
    Björn Slaug, Susanne Iwarsson, Jorge Ayala, Maria H Nilsson · 2017 · Acta Neurologica Scandinavica
  71. Speech, Voice, and Communication
    Julia Ann Johnson · 2017 · International review of neurobiology
  72. The effect of a structured medication review on quality of life in Parkinson's disease: The study protocol
    Nicol G. M. Oonk, Kris L. L. Movig, E Münster, Kirsten Koehorst-ter Huurne, Job A.M. van der Palen, Lucille D.A. Dorresteijn · 2018 · Contemporary Clinical Trials Communications
  73. Effects of Resistant Starch on Symptoms, Fecal Markers and Gut Microbiota in Parkinson’s Disease – The RESISTA-PD Trial
    Becker, Anouck, Schmartz, Georges Pierre, Gröger, Laura, Grammes, Nadja, Galata, Valentina, Philippeit, Hannah, Weiland, Jacqueline, Ludwig, Nicole, Meese, Eckart, Tierling, Sascha et al. · 2021
  74. Effects of Transcutaneous Electrical Nervous Stimulation (TENS) on Dysphonic Patients: A Systematic Review Study
    Panagiotis Plotas, Angelos A. Papadopoulos, Eirini Tsiamaki, Maria-Dimitra Apostolou, Maria-Antonia Chaniotaki, Efthimia Ganiatsou, Eleni-Marianthi Goutzeri, Thalia Kalogeraki, Elpida Karra, Maria MALLIOU et al. · 2023 · Medicina
  75. Accelerometry-derived features of physical activity, sleep and circadian rhythm relate to non-motor symptoms in individuals with isolated REM sleep behavior disorder
    Anja Ophey, V. Vinod, Sinah Röttgen, Daniel Scharfenberg, Gereon R. Fink, Michael Sommerauer, Elke Kalbe, Walter Maetzler, Clint Hansen · 2025 · Journal of Neurology
  76. Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial)
    Stéfan Halbherr, Stefanie Lerch, Sebastian Bellwald, Petra Polakova, Bettina Bannert, Marie Roumet, Roch‐Philippe Charles, Martin Alexander Walter, Corrado Bernasconi, V Lisa Halbherr et al. · 2025 · PLoS Medicine
  77. Olfactory Dysfunction as a Window Into the Heterogeneity of Parkinson Disease
    Yeeun Sun, Han Kyu Na, So Hoon Yoon, Quynh Phuong Vo, Chan Wook Park, Jung Hyun Lee, Yun Young Choi, Han Soo Yoo, Young H. Sohn, Chul Hyoung Lyoo et al. · 2025 · European Journal of Neurology
  78. The Impact of a Digital Artificial Intelligence System on the Monitoring and Self-management of Nonmotor Symptoms in People With Parkinson Disease: Proposal for a Phase 1 Implementation Study
    Edward Meinert, Madison Milne‐Ives, К. Ray Chaudhuri, Tracey Harding, John Whipps, Susan Whipps, Camille Carroll · 2022 · JMIR Research Protocols
  79. Seasonal variations of nonmotor symptoms in patients with Parkinson's disease in Southeast China
    Jingyi Wang, Kangping Xiong, Jingyuan Chao, Sheng Zhuang, Jie Li, Chun‐Feng Liu · 2022 · Chinese Medical Journal
  80. Gait Characteristics Associated with Fear of Falling in Hospitalized People with Parkinson’s Disease
    Manuela Uhlig, Tino Prell · 2023 · Sensors
  81. Association between fatigue and MDS-UPDRS in individuals with Parkinson’s disease: cross-sectional study
    Marcelle Brandão Terra, Josiane Mendes Lopes, Maria Eduarda Brandão Bueno, Luzia Aparecida Trinca, Suhaila Mahmoud Smaili · 2024 · Neurological Sciences
  82. GPR37 processing in neurodegeneration: a potential marker for Parkinson’s Disease progression rate
    Josep Argerich, Leonardo D. Garma, Marc López‐Cano, Paula Álvarez-Montoya, Laura Gómez-Acero, Víctor Fernández‐Dueñas, Ana B. Muñoz‐Manchado, Ester Aso, Adam L. Boxer, Pol Andrés‐Benito et al. · 2024 · npj Parkinson s Disease
  83. The association between indicators of health and housing in people with Parkinson’s disease
    Maria H Nilsson, Susann Ullén, Henrik Ekström, Susanne Iwarsson · 2016 · BMC Geriatrics
  84. Rating Scales for Movement Disorders With Sleep Disturbances: A Narrative Review
    Carmen Rodríguez‐Blázquez, Maria João Forjaz, Monica M. Kurtis, Roberta Balestrino, Pablo Martínez‐Martín · 2018 · Frontiers in Neurology
  85. Determinants of quality of life in Parkinson’s disease: a perspective of novel clinical subtypes
    Yun Fan, Mengwei Zhang, Xiaoniu Liang, Bo Shen, Zhiheng Xu, Shiyu Li, Tianyu Hu, Bin Wu, Jue Zhao, Yi‐Min Sun et al. · 2021 · Annals of Clinical and Translational Neurology
  86. Unmet needs in the diagnosis and treatment of Parkinson’s disease psychosis and dementia-related psychosis
    Marwan Noel Sabbagh, Gary W. Small, Stuart Isaacson, Yasar A. Torres-Yaghi, Fernando Pagán, Rajesh Pahwa · 2022 · International Journal of Psychiatry in Clinical Practice
  87. Characteristics of sleep structure in Parkinson's disease patients with hallucinations based on polysomnography
    Ruxin Gu, Jun Zhu, Min Zhong, Yinyin Jiang, Sha Zhu, Yaxi Wang, Xu Jiang, Bo Shen, Jun Yan, Li Zhang et al. · 2022 · Frontiers in Neurology
  88. The effects of microbiota abundance on symptom severity in Parkinson’s disease: A systematic review
    Eliša Papić, Valentino Rački, Mario Hero, Zoran Tomić, Nada Starčević Čizmarević, Anja Kovanda, Miljenko Kapović, Goran Hauser, Borut Peterlin, Vladimira Vuletić · 2022 · Frontiers in Aging Neuroscience
  89. Cost-utility analysis of a structured medication review compared to usual care in Parkinson’s disease
    Nicol G. M. Oonk, Lucille D.A. Dorresteijn, A. D. van den Berg, Job A.M. van der Palen, Kris L. L. Movig, Henk-Willem Nijmeijer, Mirjam E. van Kesteren, Hendrik Koffijberg · 2022 · European Journal of Clinical Pharmacology
  90. Cognitive Reserve in Isolated Rapid Eye-Movement Sleep Behavior Disorder
    Giada D’Este, Francesca Berra, Giulia Carli, Caterina Leitner, Sara Marelli, Marco Zucconi, Francesca Marta Casoni, Luigi Ferini‐Strambi, Andrea Galbiati · 2023 · Brain Sciences
  91. Clinical Evaluation of Sleep Disorders in Parkinson’s Disease
    Fulvio Lauretani, Crescenzo Testa, Marco Salvi, Irene Zucchini, Francesco Giallauria, Marcello Giuseppe Maggio · 2023 · Brain Sciences
  92. An Overview of Gastrointestinal Dysfunction in Parkinsonian Syndromes
    Lauren S. Talman, Delaram Safarpour · 2023 · Seminars in Neurology
  93. DBS amplitude setting can improve aspects of quality of life in patients with Parkinson’s disease
    Marek Baláž, Martina Bočková, Ivan Rektor · 2013 · Journal of Neural Transmission
  94. CBT Group Intervention for Depression, Anxiety, and Motor Symptoms in Parkinson's Disease: Preliminary Findings
    Isabella Berardelli, Massimo Pasquini, Maria Carmela Bloise, Lorenzo Tarsitani, Massimo Biondi, Alfredo Berardelli, Giovanni Fabbrini · 2015 · International Journal of Cognitive Therapy
  95. Comparaison de la qualité de vie de patients atteints d’atrophie multisystématisée et de maladie de Parkinson
    F. Torny, Marie Lacoste, Hélène Videaud, M. Chouly, M.-C. Parveau, Philippe Couratier · 2009 · Revue Neurologique
  96. Patient and Informant Views on Visual Hallucinations in Parkinson Disease
    Prabitha Urwyler, Tobias Nef, René M. Müri, Alison Killen, Daniel Collerton, David John Burn, Ian Grant McKeith, Urs P. Mosimann · 2014 · American Journal of Geriatric Psychiatry
  97. Actigraphic Screening for Rapid Eye Movement Sleep Behavior Disorder
    Šandala Kristián, Simona Dostálová, Jiří Nepožitek, Veronika Ibarburu Lorenzo y Losada, Petr Dušek, Evžen Růžička, Karel Šonka, David Kemlink · 2019 · medRxiv
  98. Enhancing recruitment of individuals living with frailty, multimorbidity and cognitive impairment to Parkinson’s research: experiences from the PRIME-UK cross-sectional study
    Emma Tenison, Matthew D. Smith, Danielle Pendry-Brazier, Anisha Cullen, Fiona E. Lithander, Yoav Ben‐Shlomo, Emily J. Henderson · 2024 · Age and Ageing
  99. The East London Parkinson’s disease project – a case-control study of Parkinson’s Disease in a diverse population
    Alexandra Zirra, Kamalesh C Dey, Ellen Camboe, Sheena Waters, Tahrina Haque, Brook Huxford, Harneek Chohan, Natalie Donkor, Joshua Kahan, Aaron Ben-Joseph et al. · 2025 · npj Parkinson s Disease
  100. Lower urinary tract dysfunction reported in autonomic disorders
    Ekawat Vichayanrat, Shiwen Koay, Claire Hentzen, Sarah L Wright, Amit Batla, Sara Simeoni, Valeria Iodice, Jalesh N. Panicker · 2025 · Autonomic Neuroscience